CLINICAL AND EPIDEMIOLOGICAL MANIFESTATION OF HEPATOCELLULAR CARCINOMA IN PATIENTS BELONGING TO ETHNIC GROUPS OF CAUCASIANS AND ASIANS OF NORTH-EAST ASIA
- Authors: Yuschuk N.D.1, Malov I.V.2, Baatarkhuu O...3, Savilov E.D.4, Malov S.I.5, Rasulov R.I.2, Dvornichenko V.V.2, Lkhagva-Ochir T...6, Amarsanaa J...7, Decaens T...8, Marche P.N.8
-
Affiliations:
- Moscow State University of Medicine and Dentistry
- Irkutsk State Medical University
- Mongolian National University of Medical Sciences
- Scientific Centre of Family Health and Human Reproduction, Irkutsk State Medical Academy of Continuing Education
- Irkutsk State Medical University, Irkutsk State Medical Academy of Continuing Education
- National Cancer Centre of Mongolia
- Mongolian Association for the Study of Liver Diseases
- Institut pour l’Avancee des Biosciences
- Issue: Vol 95, No 6 (2018)
- Pages: 25-31
- Section: Articles
- Submitted: 10.04.2019
- Published: 28.12.2018
- URL: https://microbiol.crie.ru/jour/article/view/324
- DOI: https://doi.org/10.36233/0372-9311-2018-6-25-31
- ID: 324
Cite item
Full Text
Abstract
About the authors
N. D. Yuschuk
Moscow State University of Medicine and Dentistry
Author for correspondence.
Email: noemail@neicon.ru
Россия
I. V. Malov
Irkutsk State Medical University
Email: noemail@neicon.ru
Россия
O. .. Baatarkhuu
Mongolian National University of Medical Sciences
Email: noemail@neicon.ru
Россия
E. D. Savilov
Scientific Centre of Family Health and Human Reproduction, Irkutsk State Medical Academy of Continuing Education
Email: noemail@neicon.ru
Россия
S. I. Malov
Irkutsk State Medical University, Irkutsk State Medical Academy of Continuing Education
Email: noemail@neicon.ru
Россия
R. I. Rasulov
Irkutsk State Medical University
Email: noemail@neicon.ru
Россия
V. V. Dvornichenko
Irkutsk State Medical University
Email: noemail@neicon.ru
Россия
T. .. Lkhagva-Ochir
National Cancer Centre of Mongolia
Email: noemail@neicon.ru
Россия
J. .. Amarsanaa
Mongolian Association for the Study of Liver Diseases
Email: noemail@neicon.ru
Россия
T. .. Decaens
Institut pour l’Avancee des Biosciences
Email: noemail@neicon.ru
Россия
P. N. Marche
Institut pour l’Avancee des Biosciences
Email: noemail@neicon.ru
Россия
References
- Бредер В.В., Косырев В.Ю., Кудашкин Н.Е., Лактионов К.К. Гепатоцеллюлярный рак в Российской Федерации как социальная и медицинская проблема. Медицинский совет. 2016, 10: 10-8.
- Кручкин Ю.Н. Современная Монголия. Энциклопедический справочник. Улан-Батор, 2011.
- Сергеев М.Н., Шевалдин А.Г., Рахманова А.Г., Слепцова С.С., Ляшенко Е.А., Шаройко В.В. Молекулярные маркеры гепатоцеллюлярной карциномы. Перспективы ранней диагностики. ВИЧ-инфекция и иммуносупрессия. 2014, 6(3): 16-23.
- Статистический бюллетень. Итоги всероссийской переписи населения 2010 года по Иркутской области. Иркутск: Иркутскстат, 2012.
- Baatarkhuu O., Kim D.Y., Bat-Ireedui P., Han K.H. Current situation of hepatocellular carcinoma in Mongolia. Oncology. 2011, 81 Suppl 1: 148-151.
- Babor T., Higgins-Biddle J.C., Saunders J.B., Monteiro M.G. AUDIT - The Alcohol Use Disorders Identification Test: Guidelines for Use in Primary Health Care (2nd edn). Geneva: World Health Organization, 2001.
- But D.Y., Lai C.L., Yuen M.F. Natural history of hepatitis-related hepatocellular carcinoma. World J. Gastroentelol. 2008, 14(11): 1652-1656.
- Cole P., Morrison A.S. Basic issues in population screening for cancer. J. Natl. Cancer Inst. 1980, 64(5): 1263-1272.
- EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma. J. Hepatol. 2018; 69(1): 182-236.
- Global hepatitis report 2017. Geneva: World Health Organization, 2017.
- Parikh N.D., Fu S., Rao H. et al. Risk assessment of hepatocellular carcinoma in patients with hepatitis C in China and the USA. Dig. Dis. Sci. 2017, 62(11): 3243-3253.
- Raza S.A., Clifford G.M., Franceschi S. Worldwide variation in the relative importance of hepatitis B and hepatitis C viruses in hepatocellular carcinoma: a systematic review. British J.Cancer. 2007, 96(7): 1127-1134.
- Trad D., Bibani N., Sabbah M. et al. Known new and emerging risk factors of hepatocellular carcinoma (review). Presse Med. 2017, 46(11): 1000-1007.
- Tsatsralt-Od B., Takahashi M., Nishizawa T. et al. Inoue J., Ulaankhuu D., Okamoto H. High prevalence of hepatitis B, C and delta virus infections among blood donors in Mongolia. Arch. Virol. 2005, 150(12): 2513-2528.
- Yapali S., Tosun N. Epidemiology and viral risk factors for hepatocellular carcinoma in the Eastern Mediterranean countries. Hepatoma Res. 2018, 4: 24-34.